These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 20637861)
1. The role of antigen presenting cells in multiple sclerosis. Chastain EM; Duncan DS; Rodgers JM; Miller SD Biochim Biophys Acta; 2011 Feb; 1812(2):265-74. PubMed ID: 20637861 [TBL] [Abstract][Full Text] [Related]
2. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774 [TBL] [Abstract][Full Text] [Related]
3. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. Mack CL; Vanderlugt-Castaneda CL; Neville KL; Miller SD J Neuroimmunol; 2003 Nov; 144(1-2):68-79. PubMed ID: 14597100 [TBL] [Abstract][Full Text] [Related]
4. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. McMahon EJ; Bailey SL; Castenada CV; Waldner H; Miller SD Nat Med; 2005 Mar; 11(3):335-9. PubMed ID: 15735651 [TBL] [Abstract][Full Text] [Related]
5. Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease. Kim BS Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067536 [TBL] [Abstract][Full Text] [Related]
6. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. Duncan DS; Miller SD PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618 [TBL] [Abstract][Full Text] [Related]
7. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. Katz-Levy Y; Neville KL; Padilla J; Rahbe S; Begolka WS; Girvin AM; Olson JK; Vanderlugt CL; Miller SD J Immunol; 2000 Nov; 165(9):5304-14. PubMed ID: 11046065 [TBL] [Abstract][Full Text] [Related]
8. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764 [TBL] [Abstract][Full Text] [Related]
9. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease. Neville KL; Dal Canto MC; Bluestone JA; Miller SD J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534 [TBL] [Abstract][Full Text] [Related]
10. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Tompkins SM; Fuller KG; Miller SD Ann N Y Acad Sci; 2002 Apr; 958():26-38. PubMed ID: 12021081 [TBL] [Abstract][Full Text] [Related]
11. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Burt RK; Padilla J; Dal Canto MC; Miller SD Blood; 1999 Oct; 94(8):2915-22. PubMed ID: 10515897 [TBL] [Abstract][Full Text] [Related]
12. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394 [TBL] [Abstract][Full Text] [Related]
13. The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Jin YH; Kang HS; Hou W; Meng L; Kim BS J Virol; 2015 Feb; 89(3):1867-78. PubMed ID: 25428872 [TBL] [Abstract][Full Text] [Related]
14. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. Neville KL; Padilla J; Miller SD J Neuroimmunol; 2002 Feb; 123(1-2):18-29. PubMed ID: 11880145 [TBL] [Abstract][Full Text] [Related]
15. Antigen-presenting cell diversity for T cell reactivation in central nervous system autoimmunity. Waisman A; Johann L J Mol Med (Berl); 2018 Dec; 96(12):1279-1292. PubMed ID: 30386908 [TBL] [Abstract][Full Text] [Related]
16. Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs. Steinbach K; Piedavent M; Bauer S; Neumann JT; Friese MA J Immunol; 2013 Nov; 191(9):4531-9. PubMed ID: 24062488 [TBL] [Abstract][Full Text] [Related]
17. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease. Bowen JL; Olson JK Viral Immunol; 2013 Aug; 26(4):223-38. PubMed ID: 23829778 [TBL] [Abstract][Full Text] [Related]
18. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. So EY; Kang MH; Kim BS Glia; 2006 Jun; 53(8):858-67. PubMed ID: 16586493 [TBL] [Abstract][Full Text] [Related]
19. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. Juedes AE; Ruddle NH J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800 [TBL] [Abstract][Full Text] [Related]
20. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Dal Canto MC; Melvold RW; Kim BS; Miller SD Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]